Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring [Phase 4]
Phase 4 clinical trial update evaluating adalimumab optimization in rheumatoid arthritis using therapeutic drug monitoring (TDM).
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Ultrasound Efficacy in Moderate Rheumatoid Arthritis [NA]
A completed clinical trial investigating ultrasound efficacy in moderate rheumatoid arthritis; results posted in 2024.
-
CLINICAL_TRIALS research · 2024-04-12Clinical Trial Update: This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry
A retrospective observational study analyzing characteristics and outcomes of participants taking Inflectra (infliximab-dyyb) within the Cor…
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.
A completed clinical trial comparing TNF inhibitors and tofacitinib in earlier lines of therapy and as monotherapy for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Cilostazol and Methotrexate in Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial evaluating cilostazol in combination with methotrexate for rheumatoid arthritis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-03-29FDA Approved: DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for the generic Diclofenac Sodium/Misoprostol product from Micro Labs Limited, authorizing its marke…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial evaluating the efficacy of iguratimod combined with tofacitab in rheumatoid arthritis (RF positive/negative).
-
FDA approval · 2024-03-21FDA Approved: DICLOFENAC SODIUM MISOPROSTOL — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Diclofenac Sodium with Misoprostol (Nivagen Pharmaceuticals, Inc.). The labeling supports use fo…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy [Phase 1]
Phase 1 trial assessing safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical effects of multiple rising subcutaneous doses…
-
FDA approval · 2024-03-15FDA Approved: ETODOLAC — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Etodolac from Amneal Pharmaceuticals NY LLC. The action adds to the existing approval for this N…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: A Study to Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug) [Phase 2]
Phase 2 study evaluating the efficacy and safety of Burfiralimab plus a DMARD in moderate to severe rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular Risk [NA]
A clinical trial evaluating weight loss and exercise to reduce cardiovascular risk in people with rheumatoid arthritis has completed and res…
-
FDA approval · 2024-03-05FDA Approved: TYENNE — Original Application (Fresenius Kabi USA, LLC)
FDA approved TYENNE (tocilizumab-AAZG) from Fresenius Kabi USA, LLC under an Original Application.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update for Hemay007 in patients with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial update exploring stopping TNF alpha inhibitors in rheumatoid arthritis.
-
FDA approval · 2024-02-22FDA Approved: ZYMFENTRA — Supplemental Application (CELLTRION USA Inc.)
The FDA approved a supplemental application for ZYMFENTRA (infliximab-dyyb) submitted by Celltrion USA Inc.
-
FDA approval · 2024-02-20FDA Approved: TERIFLUNOMIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for Teva's teriflunomide (generic) under ANDA209700.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Montelukast Use in Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial examining montelukast for rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) [Phase 3]
Phase 3 trial update for otilimab (GSK3196165) in rheumatoid arthritis shows termination with posted results.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Trivalent Chromium Treatment for Rheumatoid Arthritis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating trivalent chromium for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA
Observational study evaluating safety and efficacy of Remsima in rheumatoid arthritis; the study was terminated but results were posted on F…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial investigating the effects of Acthar on synovial inflammation in rheumatoid arthritis.
-
FDA approval · 2024-01-24FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate manufactured by Ipca Laboratories Limited. The approval updates the p…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial assessing Branebrutinib in active autoimmune diseases (systemic lupus erythematosus, primary Sjögren's syndrome) and rheumatoi…
-
FDA approval · 2023-12-28FDA Approved: MELOXICAM — Supplemental Application (AiPing Pharmaceutical, Inc)
FDA approved AiPing Pharmaceutical, Inc.'s supplemental application for MELOXICAM (meloxicam).